CD47 and neoplasm: Similarly, even in the absence of a functioning Ccr2 receptor, inhibiting peripheral macrophage infiltration, anti-CD47 treatment was efficacious and reduced tumor burden significantly as indicated by bioluminescence (Fig. 4 C and D).